Clinical trial
Intermittent Treatment With Sulfadoxine-Pyrimethamine for Malaria Control in Children: A Randomised, Double Blind, and Placebo-Controlled Clinical Trial
NCT00168948 is registered in ClinicalTrials.gov with Charite University, Berlin, Germany as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intermittent Treatment With Sulfadoxine-Pyrimethamine for Malaria Control in Children: A Randomised, Double Blind, and Placebo-Controlled Clinical Trial
- Lead sponsor
- Charite University, Berlin, Germany
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- March 31, 2003
- Completion date
- August 31, 2005
- Enrollment
- 1,200
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.